Skip to main content
SpringerLink
Log in

Molecular Staging of Melanoma: Sensitivity, Specificity, and the Search for Clinical Significance

  • Editorial
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Ribuffo D, Gradilone A, Vonella M, et al. Prognostic significance of reverse transcriptase-polymerase chain reaction–negative sentinel nodes in malignant melanoma. Ann Surg Oncol 2003;10:396–402.

    Article  PubMed  Google Scholar 

  2. McMasters KM. The Sunbelt Melanoma Trial. Ann Surg Oncol 2001;8:41S–43S.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, University of Louisville, James Graham Brown Cancer Center, Louisville, Kentucky

    Kelly M. McMasters MD, PhD

  2. Division of Surgical Oncology, University of Louisville, James Graham Brown Cancer Center, 315 E. Broadway, Suite 308, Louisville, KY, 40202

    Kelly M. McMasters MD, PhD

Authors
  1. Kelly M. McMasters MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kelly M. McMasters MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McMasters, K.M. Molecular Staging of Melanoma: Sensitivity, Specificity, and the Search for Clinical Significance. Ann Surg Oncol 10, 336–337 (2003). https://doi.org/10.1245/ASO.2003.02.013

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2003.02.013

Search

Navigation